Drug recall · April 4, 2018
Flucanazole Injection recall
Why: Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifesciences, Inc. North Brunswick, NJ 08902 By; Claris Injectables Ltd. Gujarat, India --- NDC 36000-006-10
- Lots / codes
Lot A060644, May 2018
- Quantity
- 1277 bags
- Company
- Renaissance Lakewood, LLC, Lakewood, NJ
- Distribution
- Nationwide
- Initiated
- March 2, 2018 · Voluntary: Firm initiated
- Classified
- March 23, 2018
- Reported
- April 4, 2018
- Ended
- April 10, 2020
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.